SIRIANNI, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 6.147
AS - Asia 5.098
EU - Europa 3.481
SA - Sud America 1.458
AF - Africa 318
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 16.535
Nazione #
US - Stati Uniti d'America 5.886
SG - Singapore 2.080
BR - Brasile 1.051
UA - Ucraina 981
CN - Cina 951
VN - Vietnam 900
DE - Germania 688
IT - Italia 479
AT - Austria 332
FR - Francia 262
SE - Svezia 242
IN - India 215
FI - Finlandia 153
TR - Turchia 143
CA - Canada 141
AR - Argentina 137
BD - Bangladesh 118
KR - Corea 114
HK - Hong Kong 111
SN - Senegal 107
GB - Regno Unito 86
IQ - Iraq 80
ZA - Sudafrica 80
MX - Messico 67
CO - Colombia 60
ID - Indonesia 60
RU - Federazione Russa 59
EC - Ecuador 56
PK - Pakistan 44
CL - Cile 43
MA - Marocco 40
NL - Olanda 39
VE - Venezuela 33
BE - Belgio 31
PY - Paraguay 29
UZ - Uzbekistan 26
MY - Malesia 24
AE - Emirati Arabi Uniti 23
JP - Giappone 22
SA - Arabia Saudita 22
PH - Filippine 20
PE - Perù 19
PL - Polonia 19
AU - Australia 18
UY - Uruguay 18
EG - Egitto 17
ES - Italia 17
AZ - Azerbaigian 16
DZ - Algeria 15
JO - Giordania 15
LT - Lituania 15
TN - Tunisia 15
EU - Europa 13
BO - Bolivia 12
NP - Nepal 12
PS - Palestinian Territory 12
CZ - Repubblica Ceca 11
ET - Etiopia 11
KE - Kenya 11
AL - Albania 10
BH - Bahrain 10
IL - Israele 10
LB - Libano 10
OM - Oman 10
DO - Repubblica Dominicana 8
JM - Giamaica 8
SK - Slovacchia (Repubblica Slovacca) 8
TH - Thailandia 8
GE - Georgia 7
HN - Honduras 7
PA - Panama 7
IE - Irlanda 6
KG - Kirghizistan 6
KZ - Kazakistan 6
CR - Costa Rica 5
MD - Moldavia 5
AO - Angola 4
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
CH - Svizzera 4
CY - Cipro 4
EE - Estonia 4
NI - Nicaragua 4
RS - Serbia 4
SY - Repubblica araba siriana 4
GA - Gabon 3
HU - Ungheria 3
IR - Iran 3
NG - Nigeria 3
RO - Romania 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BS - Bahamas 2
CG - Congo 2
DK - Danimarca 2
GR - Grecia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
Totale 16.506
Città #
Singapore 799
Chandler 765
Jacksonville 565
Dallas 500
San Jose 460
Ashburn 386
San Mateo 376
Boardman 333
Ho Chi Minh City 307
Dearborn 276
Beijing 274
Vienna 223
New York 209
Rende 207
Hanoi 185
Lawrence 136
Roxbury 136
Lauterbourg 128
Shanghai 123
Helsinki 115
São Paulo 115
Seoul 113
Izmir 108
Dakar 107
Hong Kong 100
Ottawa 91
Des Moines 88
Munich 84
Cambridge 70
Grafing 66
Hefei 61
Los Angeles 58
Brooklyn 56
Da Nang 51
Haiphong 44
Bremen 40
Orem 39
Ann Arbor 37
Turku 37
Wilmington 37
Johannesburg 35
Frankfurt am Main 33
Ogden 33
Inglewood 32
Brussels 31
Rio de Janeiro 31
Guangzhou 29
Seattle 28
Council Bluffs 27
Baghdad 26
Toronto 26
Tashkent 25
Pune 24
San Francisco 24
London 23
The Dalles 23
Hanover 22
Redwood City 22
Hải Dương 21
Quito 21
Columbus 20
Tokyo 20
Biên Hòa 19
Dhaka 19
Guarulhos 19
Guayaquil 19
Santa Clara 19
Amsterdam 18
Brasília 18
Mumbai 17
Porto Alegre 17
Chennai 16
Medellín 16
Montevideo 16
Tianjin 16
Cosenza 15
Curitiba 15
Lahore 15
Ninh Bình 15
Santiago 15
Amman 14
Catanzaro 14
Mexico City 14
Recife 14
Baku 13
Belo Horizonte 13
Bogotá 13
Buenos Aires 13
Campinas 13
Casablanca 13
Florence 13
Fremont 13
Houston 13
Jakarta 13
Milan 13
Montreal 13
Rome 13
Salvador 13
Cape Town 12
Düsseldorf 12
Totale 9.047
Nome #
6,6A-DIHYDRO FURO[3,2-B]FURAN-2-(5H)ONE DERIVATIVES, THEIR PREPARATION AND USE FOR TREATING TUMORS 256
A resveratrol derivative induces authophagic cell death in human breast cancer MCF-7 cell line. 221
17 β-estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocytes-derived cell line. 214
6-substituted carbazoles: synthesis and biological evaluation 213
Antioxidant activity of a mediterranean food product: "fig syrup" 210
27-hydroxycholesterol promotes adrenocortical cancer progression. 199
" L'attività antiproliferativa dell'oleuropeina e dell'idrossitirisolo nelle cellule di carcinoma mammario MCF-7 è associata all'inibizione delle MAP chinasi." 196
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment 195
27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer 190
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 190
Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: Part i 189
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines 189
Aromatase expression in prepuberal Sertoli cells: Effect of thyroid hormone 188
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 185
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 185
Activation of G-Protein-Coupled Estrogen Receptor (GPER) inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new target for ACC treatment. 178
Activation of GPER induces apoptosis in adrenocortical cancer (ACC) cells and controls tumor growth in vivo 177
17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line 175
A role of Src-tyrosine kinase in adrenal aldosterone production 172
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 170
Aromatase expression in prepuberal Sertoli cells: effects of thyroid hormone 169
17β-Estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ERα 169
Cyclooxygenase (Cox)-2 regulating transcriptional and post-transcriptional activation of aromatase is involved in Leydig cell tumor proliferation 168
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 168
Cholesterol as an endogenous ERRα agonist: A new perspective to cancer treatment 164
Cholesterol as new target for ACC therapy. 161
Antitumoral activities of curcumin and recent advances to improve its oral bioavailability 159
Aromatase expression in peripuberal Sertoli cells:: effect of thyroid hormone 157
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 157
17β-estradiol induces expression of apoptotic markers through activation of GPR30 pathway in rat Pachytene Spermatocytes 154
Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment 150
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 150
Inhibition of cholesterol synthesis by simvastatin reduces ACC growth interfering with the regulation of mitochondrial respiratory chain mediated by estrogens/estrogen receptor alpha. 149
Defining the pathway responsible for Leydig cell tumors: the role of IGF-I and estrogens. 148
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 147
Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines 143
A targetable antioxidant defense mechanism to EZH2 inhibitors enhances tumor cell vulnerability to ferroptosis 140
A role for src tyrosine kinase in regulating adrenal aldosterone production 138
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 137
27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth 136
Synthesis of a new bis(indolyl)methane that inhibits growth and induces apoptosis in human prostate cancer cells 135
Cross-talk between estrogen and IGF-II signalling in adrenocortical tumor cell proliferation. 132
XCT790 an inverse agonist of estrogen related receptor alpha (ERRalpha) inhibits cellular metabolism, motility and invasion of adrenocortical cancer cell line H295R. 132
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 132
1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer 131
Cyclooxygenase-2 (COX-2) inhibitors down-regulate aromatase expression and inhibit proliferation of tumor Leydig cells 129
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 127
Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment 126
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 124
Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers 124
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new therapy for ACC 121
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer 121
SIRT1 is involved in adrenocortical cancer growth and motility 121
Ruolo dei recettori nucleari orfani SF-1, LRH-1, SHP e DAX-1 nella regolazione dell’espressione dell'aromatasi in cellule testicolari 119
Antiestrogens upregulate estrogen receptor β expression and inhibit adrenocortical H295R cell proliferation 119
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol 119
Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells 118
Nandrolone and Stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation 116
Inhibition of Leydig tumor growth by Farnesoid X Receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy 116
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 116
Effects of tri-iodothyronine on alternative splicing events in the coding region of cytochrome P450 aromatase in immature rat Sertoli cells 115
Derivati 6,6A-Diidrofuro[3,2-b]furan-2-(5H)onici, loro preparazione e uso nel trattamento dei tumori 112
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 111
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to inhibit growth and invasion of adrenocortical carcinoma (ACC) Università della Calabria 111
Potential of Olive oil Phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies 111
Human sperm liver receptor homolog-1 (LRH-1) acts as a downstream target of the estrogen signaling pathway 110
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 110
Estrogen Related Receptor α (ERRα) As Potential Target for a New Adrenocortical Carcinoma (ACC) Therapy 108
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 107
The metabolic regulator estrogen-related receptor alpha as a therapeutic target in Adrenocortical Carcinoma (ACC). 106
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway 105
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression 105
Mitotane activates GPER-dependent pathways leading to apoptosis of human adrenocortical carcinoma H295R cell line. 103
Antiestrogens ICI 182,780 and 4-hydroxytamoxifen upregulate Erb expression and inhibit human adrenocortical cancer proliferation. 102
GPER Signaling in Spermatogenesis and Testicular Tumors 102
Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor leydig cell proliferation 101
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment 101
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells 101
Characterization of olive flower phenolic extract (OFE) and its anti-proliferative activity on MCF-7 Human Breast Cancer Cells. 101
The AP-1 family member Fos blocks transcriptional activity of the nuclear receptor steroidogenic factor 1 100
Involvment of Cyclooxygenase-2 (COX-2) in regulating estrogen-dependent Leydig cell tumor proliferation 100
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 99
Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax 99
Steroid Receptor Signaling as Targets for Resveratrol Actions in Breast and Prostate Cancer 99
G protein-coupled estrogen receptor-1 (GPER1)- and estrogen receptor α (ESR1)- dependent pathways regulate spermatocytes apoptosis. 99
Rapid estrogen signaling in spermatogenesis 96
Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression 95
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to fight adrenocortical carcinoma (ACC) progression and as useful tool to determine ACC stem cell-like proprieties. 95
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 94
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 93
The Estrogen Related Receptor α (ERRα) inverse agonist XCT-790 reduces adrenocortical cancer (ACC) H295R cells growth in vitro and in vivo. 92
Food System Transformation and Gut Microbiota Transition: Evidence on Advancing Obesity, Cardiovascular Diseases, and Cancers-A Narrative Review 91
Il tumore delle cellule del Leydig: il ruolo di IGF-I e degli estrogeni 91
GPR30 mediates estradiol-proliferative effects on GC-1 mouse spermatogonial cell line through ERK/Fos activation 91
The Novel Estrogen Receptor GPR30 Mediates the Proliferative Effects Induced by 17beta-Estradiol on GC-1 Mouse Spermatogonial Cell Line 91
Inhibition of Src tyrosine kinase stimulates adrenal androgen production 91
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 91
Role of scaffold protein Proline-, Glutamic acid-, and Leucine-Rich protein 1 (PELP1) in the modulation of adrenocortical cancer cell growth 89
Role of IGF-I and estrogens in Leydig cell tumorogenesis. 88
L’attivazione selettiva di GPER inibisce la proliferazione e attiva l’apoptosi in cellule di Leydig tumorali. 88
Totale 13.428
Categoria #
all - tutte 90.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 0 0 0 0 0 0 129 10 100
2021/20221.700 9 239 10 82 203 74 17 410 18 16 189 433
2022/20231.832 244 251 126 219 252 155 14 185 195 56 73 62
2023/20241.154 119 50 77 55 67 313 38 43 77 52 40 223
2024/20252.394 163 330 77 135 155 105 59 145 451 189 247 338
2025/20266.907 879 306 850 647 1.385 493 812 403 586 546 0 0
Totale 16.703